Dana Farber-Merrimack Valley is a clinical research site located in Methuen, Massachusetts, United States 01844.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Dana Farber-Merrimack Valley has participated in 15 clinical trials with 14 currently active.
Therapeutic areas: Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma.
Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, NRG Oncology.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Dana Farber-Merrimack Valley has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana Farber-Merrimack Valley has 15 clinical trials on record, with 14 currently active. Their work covers Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma.
Yes — Dana Farber-Merrimack Valley holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.